China Rural Health Initiative Follow up Study
CRHIFU
1 other identifier
observational
9,164
1 country
5
Brief Summary
China Rural Health Initiative (CRHI), a large-scale, factorial, cluster-randomized, controlled trial was conducted in 120 villages selected from 5 Northern Provinces of rural China between 2010 and 2012. Two interventions were evaluated through CRHI. One is the standard disease management program of individuals at high risk of cardiovascular disease delivered by Primary Care Providers (village doctors). Another one is a community-based Salt Reduction program delivered by community health educators. CRHI study interventions had ended for two years now and provide a good opportunity for us to understand whether its effects could be prolonged to a longer term. This study wants to evaluate the effects of CRHI interventions at 2 years after the end of CRHI (from Sep 2014 to Feb 2015). In this follow-up survey, the baseline cohort of 5050 and post-intervention cohort of 4887 CRHI participants who were randomly selected from the 120 villages from 5 northern provinces of rural China will be recruited for the follow up study from Sep 2014 to Feb 2015. A questionnaire derived from CRHI baseline and post-intervention surveys will be used to collect data on disease history, medication use, care seeking patterns, lifestyle factors and so on. Weight, height, blood pressure and heart rate will be measured in the standard ways.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2014
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 2, 2014
CompletedFirst Posted
Study publicly available on registry
February 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedFebruary 27, 2017
January 1, 2016
1.4 years
September 2, 2014
February 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mean systolic blood pressure level among all participants and those at high risk
from baseline and post-intervention to the follow up
Secondary Outcomes (8)
Proportion of individuals regularly visiting the village clinic among all participants and high-risk patients
from baseline and post-intervention to the follow up
Proportion of individuals receiving lifestyle advice among all participants and high-risk patients
from baseline and post-intervention to the follow up
Proportion of individuals treated with a blood pressure lowering agent among all participants and high-risk patients
from baseline and post-intervention to the follow up
Proportion of individuals treated with aspirin among all participants and high-risk patients
from baseline and post-intervention to the follow up
Proportion of individuals having knowledge on salt reduction among all participants and high-risk patients
from baseline and post-intervention to the follow up
- +3 more secondary outcomes
Study Arms (4)
PCP and SRS
participants had received two interventions (PCP and SRS)
PCP only
participants had received PCP intervention only
SRS only
participants had received SRS intervention only
control group
participants had received usual care (neither PCP nor SRS)
Interventions
PCP is short for the standard disease management program of individuals at high risk of cardiovascular disease delivered by Primary Care Providers (village doctors).
SRS is short for a community-based Salt Reduction program delivered by community health educators.
Eligibility Criteria
The baseline cohort of 5050 and post-intervention cohort of 4887 CRHI participants who were randomly selected from the 120 villages from 5 northern provinces (Liaoning, Hebei, Shanxi, Shaanxi and Ningxia) of rural China will be recruited for the follow up study.
You may qualify if:
- Individuals had participated the baseline or post-intervention survey.
You may not qualify if:
- Death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Hebei Province Center for Disease Prevention and Control ,China
Shijiazhuang, Hebei, 050000, China
The First Hospital Of China Medical University
Shenyang, Liaoning, 110000, China
Ningxia Medical University School of Public Health
Yinchuan, Ningxia, 750000, China
Xi'an Jiaotong University
Xi'an, Shaanxi, 710000, China
Changzhi Medical College, China
Changzhi, Shanxi, 046000, China
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Yangfeng Wu, PhD
The George Institute for Global Health, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 2, 2014
First Posted
February 23, 2015
Study Start
September 1, 2014
Primary Completion
February 1, 2016
Study Completion
August 1, 2016
Last Updated
February 27, 2017
Record last verified: 2016-01